TRENDS AND TRUTH IN LIFE SCIENCES INVESTMENT
Biotech and Money Investor Perception Survey 2017
The mission of this survey and report is to create unique and actionable insight into investor attitudes, biases and preferences in healthcare opportunities in Europe, that can be used by our community to inform their decisions and strategy.
Biotech & Money’s investor survey and interviews were conducted across the range of the investment community. In total, 177 people completed the survey and we directly interviewed 10. Most of those taking part in the survey were investors; those from the Buy-Side made up nearly 70% of respondents.
Clear trends and opinions emerged, especially on Biotech company management skill-sets, M&A expectations, investment trends, and investment risks. At the same time, the survey looked at several myths and attitudes assumed to be common in the Biotech sector: some were supported by this survey, some weren’t.
35+ INNOVATIVE LIFE SCIENCE COMPANIES YOU'LL WANT TO MEET IN 2017
Who are the innovative biotech and medtech companies presenting at Biotech and Money / Medtech and Money London 2017?
What follows in this document is a summary of over 35 innovative and notable biotech, medtech and diagnostics companies that will be showcasing at the 3rd annual Biotech and Money / Medtech and Money London 2017 conference. The list represents a range of start-ups, established companies and publicly listed firms, from across the UK and EU, who will be presenting across the 2-day investment and partnering conference. They are firms that, if you don’t already have a relationship with, their CEOs are individuals you should want to get to know in 2017.
FAMILY OFFICE HEALTHCARE FORUM
The role of SFOs in the healthcare sector
A topic that we’ve found to be of almost universal interest to companies of all sizes in our network, is family offices, who are notoriously, but understandably, quiet and choose to fly under the radar. However, we’ve also been sensing a growing interest in the healthcare sector as an investment opportunity from FOs
40+ Must Know Life Science Investors
Who are some of the leading international investors most active this side of the Atlantic?
What follows in this ebook is a summary of over 40 of the life science industry’s most notable and active venture capital, corporate venture, strategic investors and PE / crossovers. The geography of this list is primarily UK and EU, but with several key US firms also listed. They represent a combined assets under management of over $50bn across therapeutics, diagnostics and medtech.
Medtech and Money: The Key Enablers
What are the key factors for medtechs to attract investment?
In this ebook we’ll explore how the medtech sector is affected by economic climate, how it can weather political change, what’s hot in the sector right now and what steps medtech startups can take to find the funding that’s right for them.
Welcome to the family
Family Office Investment in Life Sciences: How to find, approach and foster a Relationship with High Net Worth Families
So you’re in a life sciences start up – you have some amazing, ground-breaking science that you want to share with the world, and you’re looking for funding to get it off the ground. What are your options? A traditional thought process might be to get in touch with venture capital primarily, whilst also exploring non-dilutive funding options. But 2016 is a different kettle of fish...
Far from the madding crowd
How Equity Investment Platforms are taking Life Sciences by storm
This ebook will guide you through the basics of equity crowdfunding, how their models are taking life sciences by storm, and finally offer some advice to startups wishing to explore this route of fundraising, with expert advice from industry leaders Christian Girard, of Orphan Drugs Industry, and Gonçalo de Vasconcelos, of crowdfunding platform SyndicateRoom.
